De Santo C[au] - Search Results

Year	Number of Results
1987	2
1989	2
1996	2
1998	1
2003	4
2004	2
2005	1
2006	2
2008	2
2009	1
2010	1
2012	1
2013	1
2014	1
2015	5
2016	2
2017	3
2018	6
2019	6
2020	1
2021	4
2022	2

1

Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity.

Fultang L, Booth S, Yogev O, Martins da Costa B, Tubb V, Panetti S, Stavrou V, Scarpa U, Jankevics A, Lloyd G, Southam A, Lee SP, Dunn WB, Chesler L, Mussai F, De Santo C. Fultang L, et al. Among authors: de santo c. Blood. 2020 Sep 3;136(10):1155-1160. doi: 10.1182/blood.2019004500. Blood. 2020. PMID: 32573723 Free PMC article.

2

MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers.

Fultang L, Panetti S, Ng M, Collins P, Graef S, Rizkalla N, Booth S, Lenton R, Noyvert B, Shannon-Lowe C, Middleton G, Mussai F, De Santo C. Fultang L, et al. Among authors: de santo c. EBioMedicine. 2019 Sep;47:235-246. doi: 10.1016/j.ebiom.2019.08.025. Epub 2019 Aug 25. EBioMedicine. 2019. PMID: 31462392 Free PMC article.

3

Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies.

Fultang L, Gneo L, De Santo C, Mussai FJ. Fultang L, et al. Among authors: de santo c. Front Oncol. 2021 May 20;11:674720. doi: 10.3389/fonc.2021.674720. eCollection 2021. Front Oncol. 2021. PMID: 34094976 Free PMC article. Review.

4

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells.

Collins PJ, Fox CP, George L, Pearce H, Ryan G, De Santo C, Mussai F, Lewis D, Long H, Shannon-Lowe C. Collins PJ, et al. Among authors: de santo c. Blood. 2021 Jan 14;137(2):203-215. doi: 10.1182/blood.2020005611. Blood. 2021. PMID: 33443553 Free article.

5

Molecular basis and current strategies of therapeutic arginine depletion for cancer.

Fultang L, Vardon A, De Santo C, Mussai F. Fultang L, et al. Among authors: de santo c. Int J Cancer. 2016 Aug 1;139(3):501-9. doi: 10.1002/ijc.30051. Epub 2016 Apr 15. Int J Cancer. 2016. PMID: 26913960 Free article. Review.

6

Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.

Fultang L, Gamble LD, Gneo L, Berry AM, Egan SA, De Bie F, Yogev O, Eden GL, Booth S, Brownhill S, Vardon A, McConville CM, Cheng PN, Norris MD, Etchevers HC, Murray J, Ziegler DS, Chesler L, Schmidt R, Burchill SA, Haber M, De Santo C, Mussai F. Fultang L, et al. Among authors: de santo c. Cancer Res. 2019 Feb 1;79(3):611-624. doi: 10.1158/0008-5472.CAN-18-2139. Epub 2018 Dec 13. Cancer Res. 2019. PMID: 30545920 Free PMC article.

7

Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients.

Khanna S, Graef S, Mussai F, Thomas A, Wali N, Yenidunya BG, Yuan C, Morrow B, Zhang J, Korangy F, Greten TF, Steinberg SM, Stetler-Stevenson M, Middleton G, De Santo C, Hassan R. Khanna S, et al. Among authors: de santo c. Clin Cancer Res. 2018 Jun 15;24(12):2859-2872. doi: 10.1158/1078-0432.CCR-17-3757. Epub 2018 Mar 30. Clin Cancer Res. 2018. PMID: 29602801 Free PMC article.

8

Targeting the arginine metabolic brake enhances immunotherapy for leukaemia.

Mussai F, Wheat R, Sarrou E, Booth S, Stavrou V, Fultang L, Perry T, Kearns P, Cheng P, Keeshan K, Craddock C, De Santo C. Mussai F, et al. Among authors: de santo c. Int J Cancer. 2019 Oct 15;145(8):2201-2208. doi: 10.1002/ijc.32028. Epub 2019 Jan 11. Int J Cancer. 2019. PMID: 30485425 Free PMC article. Clinical Trial.

9

Derangement of immune responses by myeloid suppressor cells.

Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, Gallina G, Zanovello P, Bronte V. Serafini P, et al. Among authors: de santo c. Cancer Immunol Immunother. 2004 Feb;53(2):64-72. doi: 10.1007/s00262-003-0443-2. Epub 2003 Oct 30. Cancer Immunol Immunother. 2004. PMID: 14593498 Review.

10

Interaction between invariant NKT cells and myeloid-derived suppressor cells in cancer patients: evidence and therapeutic opportunities.

Mussai F, De Santo C, Cerundolo V. Mussai F, et al. Among authors: de santo c. J Immunother. 2012 Jul;35(6):449-59. doi: 10.1097/CJI.0b013e31825be926. J Immunother. 2012. PMID: 22735803 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results